Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2144255757', 'doi': 'https://doi.org/10.1128/aac.00157-11', 'title': 'Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes', 'display_name': 'Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes', 'publication_year': 2011, 'publication_date': '2011-08-02', 'ids': {'openalex': 'https://openalex.org/W2144255757', 'doi': 'https://doi.org/10.1128/aac.00157-11', 'mag': '2144255757', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/21807982', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/3187001'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1128/aac.00157-11', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S47215897', 'display_name': 'Antimicrobial Agents and Chemotherapy', 'issn_l': '0066-4804', 'issn': ['0066-4804', '1070-6283', '1098-6596'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320263', 'host_organization_name': 'American Society for Microbiology', 'host_organization_lineage': ['https://openalex.org/P4310320263'], 'host_organization_lineage_names': ['American Society for Microbiology'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'green', 'oa_url': 'https://doi.org/10.1128/aac.00157-11', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5062560822', 'display_name': 'Kendra E. Hightower', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kendra E. Hightower', 'raw_affiliation_strings': ['GlaxoSmithKline; Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline; Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031907388', 'display_name': 'Ruolan Wang', 'orcid': 'https://orcid.org/0009-0005-2338-8209'}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ruolan Wang', 'raw_affiliation_strings': ['GlaxoSmithKline; Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline; Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013560118', 'display_name': 'Felix Deanda', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Felix DeAnda', 'raw_affiliation_strings': ['GlaxoSmithKline; Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline; Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048833977', 'display_name': 'Brian A. Johns', 'orcid': 'https://orcid.org/0000-0001-5526-3682'}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Brian A. Johns', 'raw_affiliation_strings': ['GlaxoSmithKline; Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline; Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091203226', 'display_name': 'Kurt Weaver', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kurt Weaver', 'raw_affiliation_strings': ['GlaxoSmithKline; Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline; Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077104742', 'display_name': 'Yongping Shen', 'orcid': 'https://orcid.org/0000-0003-2465-479X'}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yingnian Shen', 'raw_affiliation_strings': ['GlaxoSmithKline; Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline; Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052473887', 'display_name': 'Ginger H. Tomberlin', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ginger H. Tomberlin', 'raw_affiliation_strings': ['GlaxoSmithKline; Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline; Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086725374', 'display_name': 'H. Luke Carter', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'H. Luke Carter', 'raw_affiliation_strings': ['GlaxoSmithKline; Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline; Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038161989', 'display_name': 'Timothy M Broderick', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Timothy Broderick', 'raw_affiliation_strings': ['GlaxoSmithKline; Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline; Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102157056', 'display_name': 'Sigethy Scott', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Scott Sigethy', 'raw_affiliation_strings': ['GlaxoSmithKline; Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline; Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101790533', 'display_name': 'Takahiro Seki', 'orcid': 'https://orcid.org/0000-0002-3952-8684'}, 'institutions': [{'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Takahiro Seki', 'raw_affiliation_strings': ['Shionogi & Co., Ltd., Osaka, Japan'], 'affiliations': [{'raw_affiliation_string': 'Shionogi & Co., Ltd., Osaka, Japan', 'institution_ids': ['https://openalex.org/I4210118477']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102978015', 'display_name': 'Masanori Kobayashi', 'orcid': 'https://orcid.org/0000-0002-9067-859X'}, 'institutions': [{'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masanori Kobayashi', 'raw_affiliation_strings': ['Shionogi & Co., Ltd., Osaka, Japan'], 'affiliations': [{'raw_affiliation_string': 'Shionogi & Co., Ltd., Osaka, Japan', 'institution_ids': ['https://openalex.org/I4210118477']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5056086220', 'display_name': 'Mark Underwood', 'orcid': 'https://orcid.org/0000-0002-6803-2346'}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark R. Underwood', 'raw_affiliation_strings': ['GlaxoSmithKline; Research Triangle Park, North Carolina'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline; Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 11.353, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 212, 'citation_normalized_percentile': {'value': 0.999907, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 98, 'max': 99}, 'biblio': {'volume': '55', 'issue': '10', 'first_page': '4552', 'last_page': '4559'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'Efficacy and Safety of Antiretroviral Therapy for HIV', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'Efficacy and Safety of Antiretroviral Therapy for HIV', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10112', 'display_name': 'Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12827', 'display_name': 'Nucleotide Metabolism and Enzyme Regulation', 'score': 0.9916, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/elvitegravir', 'display_name': 'Elvitegravir', 'score': 0.98674613}, {'id': 'https://openalex.org/keywords/dolutegravir', 'display_name': 'Dolutegravir', 'score': 0.96925616}, {'id': 'https://openalex.org/keywords/raltegravir', 'display_name': 'Raltegravir', 'score': 0.9512707}, {'id': 'https://openalex.org/keywords/integrase-inhibitor', 'display_name': 'Integrase inhibitor', 'score': 0.7858721}, {'id': 'https://openalex.org/keywords/integrase-inhibitors', 'display_name': 'Integrase Inhibitors', 'score': 0.473015}], 'concepts': [{'id': 'https://openalex.org/C2777068322', 'wikidata': 'https://www.wikidata.org/wiki/Q2740966', 'display_name': 'Elvitegravir', 'level': 5, 'score': 0.98674613}, {'id': 'https://openalex.org/C2779502633', 'wikidata': 'https://www.wikidata.org/wiki/Q937224', 'display_name': 'Dolutegravir', 'level': 5, 'score': 0.96925616}, {'id': 'https://openalex.org/C2780404665', 'wikidata': 'https://www.wikidata.org/wiki/Q421552', 'display_name': 'Raltegravir', 'level': 5, 'score': 0.9512707}, {'id': 'https://openalex.org/C14430832', 'wikidata': 'https://www.wikidata.org/wiki/Q412550', 'display_name': 'Integrase', 'level': 3, 'score': 0.9382482}, {'id': 'https://openalex.org/C2777302000', 'wikidata': 'https://www.wikidata.org/wiki/Q412251', 'display_name': 'Integrase inhibitor', 'level': 5, 'score': 0.7858721}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.55944824}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.5403327}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.45929}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.38774037}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.2907812}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.21652022}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.21612671}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.103479624}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.07917318}], 'mesh': [{'descriptor_ui': 'D004279', 'descriptor_name': 'DNA, Viral', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D019427', 'descriptor_name': 'HIV Integrase', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D019428', 'descriptor_name': 'HIV Integrase Inhibitors', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D006575', 'descriptor_name': 'Heterocyclic Compounds, 3-Ring', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D011760', 'descriptor_name': 'Pyrrolidinones', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D015363', 'descriptor_name': 'Quinolones', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D019943', 'descriptor_name': 'Amino Acid Substitution', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018076', 'descriptor_name': 'DNA, Complementary', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004279', 'descriptor_name': 'DNA, Viral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D024882', 'descriptor_name': 'Drug Resistance, Viral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005838', 'descriptor_name': 'Genotype', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019427', 'descriptor_name': 'HIV Integrase', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D019427', 'descriptor_name': 'HIV Integrase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019428', 'descriptor_name': 'HIV Integrase Inhibitors', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D019428', 'descriptor_name': 'HIV Integrase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D019428', 'descriptor_name': 'HIV Integrase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006575', 'descriptor_name': 'Heterocyclic Compounds, 3-Ring', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006575', 'descriptor_name': 'Heterocyclic Compounds, 3-Ring', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010078', 'descriptor_name': 'Oxazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011728', 'descriptor_name': 'Pyridones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011760', 'descriptor_name': 'Pyrrolidinones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011760', 'descriptor_name': 'Pyrrolidinones', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D015363', 'descriptor_name': 'Quinolones', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D015363', 'descriptor_name': 'Quinolones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068898', 'descriptor_name': 'Raltegravir Potassium', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1128/aac.00157-11', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S47215897', 'display_name': 'Antimicrobial Agents and Chemotherapy', 'issn_l': '0066-4804', 'issn': ['0066-4804', '1070-6283', '1098-6596'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320263', 'host_organization_name': 'American Society for Microbiology', 'host_organization_lineage': ['https://openalex.org/P4310320263'], 'host_organization_lineage_names': ['American Society for Microbiology'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc3187001', 'pdf_url': 'https://europepmc.org/articles/pmc3187001?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187001', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/21807982', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1128/aac.00157-11', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S47215897', 'display_name': 'Antimicrobial Agents and Chemotherapy', 'issn_l': '0066-4804', 'issn': ['0066-4804', '1070-6283', '1098-6596'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320263', 'host_organization_name': 'American Society for Microbiology', 'host_organization_lineage': ['https://openalex.org/P4310320263'], 'host_organization_lineage_names': ['American Society for Microbiology'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.82, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 39, 'referenced_works': ['https://openalex.org/W1489859663', 'https://openalex.org/W1539825989', 'https://openalex.org/W1546094383', 'https://openalex.org/W1603290129', 'https://openalex.org/W1604319891', 'https://openalex.org/W1846959000', 'https://openalex.org/W1964048276', 'https://openalex.org/W1967390610', 'https://openalex.org/W1979989142', 'https://openalex.org/W1983837630', 'https://openalex.org/W1990069515', 'https://openalex.org/W2012666111', 'https://openalex.org/W2016408686', 'https://openalex.org/W2025344323', 'https://openalex.org/W2025952824', 'https://openalex.org/W2030017358', 'https://openalex.org/W2040729797', 'https://openalex.org/W2042656735', 'https://openalex.org/W2044794863', 'https://openalex.org/W2046412323', 'https://openalex.org/W2052258044', 'https://openalex.org/W2056182928', 'https://openalex.org/W2072692397', 'https://openalex.org/W2077216092', 'https://openalex.org/W2088424911', 'https://openalex.org/W2094621241', 'https://openalex.org/W2109360985', 'https://openalex.org/W2114822477', 'https://openalex.org/W2117072114', 'https://openalex.org/W2139876724', 'https://openalex.org/W2139960736', 'https://openalex.org/W2149150781', 'https://openalex.org/W2150226114', 'https://openalex.org/W2150504993', 'https://openalex.org/W2152880150', 'https://openalex.org/W2154190260', 'https://openalex.org/W2165004541', 'https://openalex.org/W2171711893', 'https://openalex.org/W218277912'], 'related_works': ['https://openalex.org/W2747838037', 'https://openalex.org/W2617245465', 'https://openalex.org/W2605669224', 'https://openalex.org/W2588666346', 'https://openalex.org/W2474869173', 'https://openalex.org/W2392594014', 'https://openalex.org/W2144255757', 'https://openalex.org/W2032743590', 'https://openalex.org/W1994342377', 'https://openalex.org/W1489859663'], 'abstract_inverted_index': {'ABSTRACT': [0], 'The': [1, 135], 'integrase': [2, 46], 'inhibitor': [3], '(INI)': [4], 'dolutegravir': [5], '(DTG;': [6], 'S/GSK1349572)': [7], 'has': [8], 'significant': [9], 'activity': [10], 'against': [11], 'HIV-1': [12], 'isolates': [13], 'with': [14, 45, 77, 125, 157, 195], 'raltegravir': [15], '(RAL)-': [16], 'and': [17, 35, 63, 87, 107, 132, 225], 'elvitegravir': [18], '(ELV)-associated': [19], 'resistance': [20, 30, 65, 238], 'mutations.': [21, 66], 'As': [22], 'an': [23, 78, 149, 216], 'initial': [24], 'step': [25], 'in': [26, 148, 151], 'characterizing': [27], 'the': [28, 39, 101, 152, 158, 164, 168, 185, 196, 211, 220, 228], 'different': [29], 'profiles': [31], 'of': [32, 42, 53, 80, 95, 137, 163, 170, 187, 219, 222, 231], 'DTG,': [33], 'RAL,': [34], 'ELV,': [36], 'we': [37], 'determined': [38], 'dissociation': [40, 230], 'rates': [41], 'these': [43], 'INIs': [44], '(IN)-DNA': [47], 'complexes': [48, 127, 174], 'containing': [49, 128], 'a': [50, 71, 88, 138, 202], 'broad': [51], 'panel': [52], 'IN': [54, 57, 165], 'proteins,': [55], 'including': [56], 'substitutions': [58, 166], 'corresponding': [59], 'to': [60, 141, 155, 180, 200, 206, 235], 'signature': [61], 'RAL': [62, 104, 188], 'ELV': [64, 108], 'DTG': [67, 124, 171, 199, 232], 'dissociates': [68], 'slowly': [69], 'from': [70, 172], 'wild-type': [72], 'IN-DNA': [73, 126, 173], 'complex': [74], 'at': [75, 117], '37°C': [76], 'off-rate': [79, 153, 169, 186, 213], '2.7': [81], '×': [82], '10': [83], '−6': [84], 's': [85], '−1': [86], 'dissociative': [89], 'half-life': [90], '(': [91, 113], 't': [92, 114], '1/2': [93, 115], ')': [94], '71': [96], 'h,': [97], 'significantly': [98, 176], 'longer': [99], 'than': [100, 184], 'half-lives': [102], 'for': [103, 123, 198], '(8.8': [105], 'h)': [106, 120], '(2.7': [109], 'h).': [110], 'Prolonged': [111], 'binding': [112], ',': [116], 'least': [118], '5': [119, 179], 'was': [121, 175], 'observed': [122], 'E92,': [129], 'Y143,': [130], 'Q148,': [131], 'N155': [133, 145], 'substitutions.': [134], 'addition': [136], 'second': [139], 'substitution': [140], 'either': [142], 'Q148': [143], 'or': [144, 189], 'typically': [146], 'resulted': [147], 'increase': [150], 'compared': [154], 'that': [156, 210, 227], 'single': [159], 'substitution.': [160], 'For': [161], 'all': [162], 'tested,': [167], 'slower': [177], '(from': [178], '40': [181], 'times': [182], 'slower)': [183], 'ELV.': [190], 'These': [191], 'data': [192], 'are': [193], 'consistent': [194], 'potential': [197], 'have': [201], 'higher': [203], 'genetic': [204], 'barrier': [205], 'resistance,': [207, 224], 'provide': [208], 'evidence': [209], 'INI': [212, 223], 'may': [214, 233], 'be': [215], 'important': [217], 'component': [218], 'mechanism': [221], 'suggest': [226], 'slow': [229], 'contribute': [234], 'its': [236], 'distinctive': [237], 'profile.': [239]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2144255757', 'counts_by_year': [{'year': 2024, 'cited_by_count': 5}, {'year': 2023, 'cited_by_count': 10}, {'year': 2022, 'cited_by_count': 11}, {'year': 2021, 'cited_by_count': 10}, {'year': 2020, 'cited_by_count': 12}, {'year': 2019, 'cited_by_count': 13}, {'year': 2018, 'cited_by_count': 13}, {'year': 2017, 'cited_by_count': 17}, {'year': 2016, 'cited_by_count': 14}, {'year': 2015, 'cited_by_count': 34}, {'year': 2014, 'cited_by_count': 29}, {'year': 2013, 'cited_by_count': 24}, {'year': 2012, 'cited_by_count': 18}], 'updated_date': '2024-09-17T16:37:52.135123', 'created_date': '2016-06-24'}